No results for ‘’
Brooks Laboratories Ltd
₹65.69
(2.88%)
Mon, 14 Sept 2026, 09:56 pm
Health Technology
Pharmaceuticals: Major
24.5KBrooks Laboratories Share Price Live Chart
1 Day
(2.88%)
No Result Found
Summary
Market Cap (in Cr)
193.68
Net Profit (in Cr)
-9.97
P/B
3.24
Sector P/E
33.76
P/E
0
EV/EBITDA
0
Debt/Equity (Industry)
0.24
Interest Cover (Industry)
9.79
ROCE (Industry)
14.04
RONW (Industry)
13.17
ROE
0
ROCE
0
Debt/Equity
0.08
EPS (TTM)
7.33
Dividend Yield
0
Book Value
39.27
Interest Cover
-8.50
Analysis
all
- Debt is covered by short term assets, assets are 1.2x debt.
- Brooks Laboratories's cash and other short term assets cover its long term commitments.
- Brooks Laboratories's level of debt (29.4%) compared to net worth is satisfactory (less than 40%).
- The tenure for the Brooks Laboratories board of directors is about average.
- Rajesh's remuneration is lower than average for companies of similar size in India.
- Unable to calculate sustainability of dividends as Brooks Laboratories has not reported any payouts.
- Unable to evaluate Brooks Laboratories's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Brooks Laboratories's dividend against the top 25% market benchmark as the company has not reported any payouts.
- Brooks Laboratories's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
- Operating cash flow is negative therefore debt is not well covered.
Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 52.62 | 52.62 | 52.62 | 52.62 | 52.62 |
| FII | 0.17 | 0.09 | 0.01 | 0 | 0.05 |
| DII | 10.38 | 10.38 | 10.38 | 10.38 | 10.38 |
| Public | 36.84 | 36.91 | 37.00 | 37.00 | 36.95 |
| Government | 0 | 0 | 0 | 0 | 0 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 91.28 | 78.38 | 72.46 | 65.48 | 59.56 | 52.58 | 39.68 |
| Fibonacci | 78.38 | 73.45 | 70.41 | 65.48 | 60.55 | 57.51 | 52.58 |
| Camarilla | 70.09 | 68.91 | 67.72 | 65.48 | 65.36 | 64.18 | 62.99 |
Pivots Level: Classic
R3
+25.80
91.28
R2
+12.90
78.38
R1
+6.98
72.46
S1
-5.92
59.56
S2
-12.90
52.58
S3
-25.80
39.68
Moving Average
Period
Value
10-EMA
64.68
20-EMA
64.25
30-EMA
64.14
50-EMA
64.21
100-EMA
65.61
200-EMA
74.50
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 29 May 2026 | board-meetings | Quarterly Results | |
| 06 Feb 2026 | board-meetings | Quarterly Results | |
| 14 Nov 2025 | board-meetings | Quarterly Results | |
| 08 Sept 2025 | agm | ||
| 19 Dec 2024 | egm | ||
| 02 Sept 2024 | agm | ||
| 12 Aug 2024 | agm | Annual General Meeting | 13 Sept 2024 |
| 30 Aug 2023 | agm | ||
| 14 Aug 2023 | agm | Annual General Meeting | 15 Sept 2023 |
| 18 Jul 2023 | rights | 1:16 Rights Issue of Equity Shares | 28 Jul 2023 |
Peer Comparison
Brooks Laboratories Ltd
Divis Laboratories Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Dr Reddys Laboratories Ltd
Sun Pharmaceutical Industries Ltd
Brooks Laboratories Ltd About
Brooks Laboratories is a pharmaceutical manufacturing company working on contract basis and have its own marketing team to cater the critical care segment.
Industry
Pharmaceuticals - Indian - Bulk Drugs & Formln
Founded
2002
Headquarters
CEO
Employees
Contact
Website
http://www.brookslabs.net
cs@brookslabs.net
Phone
91-1795-654001/02/03
Location
Village Kishanpura, Nilagarh Road Baddi, Solan, Himachal Pradesh, 174101
Brooks Laboratories Ltd Company History
| Year | History |
|---|---|
| 2013 |
|
| 2014 |
|
| 2015 |
|
| 2016 |
|
| 2023 |
|
Deals
| Client Name | Deal Type | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|---|
| RAMESH THAKURDAS JAISINGHANI | bulk | Sell | 170803 | 50.55 | 08 May 2026 |
| ATUL RANCHAL | bulk | Sell | 395011 | 136.4 | 14 Nov 2024 |
| ONE UP FINANCIAL CONSULTANTS PVT LTD | bulk | Buy | 400000 | 136.4 | 14 Nov 2024 |
| ARYAN MAHAJAN | bulk | Sell | 480000 | 137.4 | 14 Nov 2024 |
| ATUL RANCHAL | bulk | Sell | 200000 | 137.4 | 14 Nov 2024 |
| RR FAMILY TRUST | bulk | Buy | 218300 | 137.4 | 14 Nov 2024 |
| SARAVANA GLOBAL HOLDINGS LIMITED | bulk | Sell | 138398 | 92.12 | 16 May 2024 |
| MUKUL MAHESHWARI (HUF) | bulk | Buy | 131656 | 104.67 | 21 Apr 2022 |
| MUKUL MAHESHWARI (HUF) | bulk | Sell | 38423 | 104.83 | 21 Apr 2022 |
| GUTTIKONDA VARA LAKSHMI | bulk | Sell | 160000 | 89.25 | 03 Mar 2022 |
Frequently Asked Questions
1.What is the stock price of Brooks Laboratories Ltd?
As of 15/09/2026 at 3:26 AM, Brooks Laboratories Ltd shares are trading at ₹65.69.
2.What is the market cap. of Brooks Laboratories Ltd?
As of 15/09/2026, the market capitalization of Brooks Laboratories Ltd is ₹187.26 crore.
3.When was Brooks Laboratories Ltd founded?
Brooks Laboratories Ltd was founded in 2002.
4.What are the P/E and P/B ratios of Brooks Laboratories Ltd?
As of 15/09/2026, Brooks Laboratories Ltd has a P/E ratio of 14.65 and a P/B ratio of 3.24.
5.How can I buy shares of Brooks Laboratories Ltd?
You can buy shares of Brooks Laboratories Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.
6.What is the shareholding pattern of Brooks Laboratories Ltd?
As of March,2026, promoters hold 52.62% in Brooks Laboratories Ltd, while FIIs, DIIs and public shareholders hold 0.17%, 10.38% and 36.84%, respectively.
7.Does Brooks Laboratories Ltd pay dividends?
No, Brooks Laboratories Ltd does not pay dividends to eligible shareholders currently.
8.What are the latest financial results of Brooks Laboratories Ltd?
For January,2024, Brooks Laboratories Ltd reported revenue of ₹82.34 crore and a net profit of ₹-9.97 crore.
9.What is the Stock symbol of Brooks Laboratories Ltd?
BROOKS is the stock symbol of Brooks Laboratories Ltd.